Kamat S, Veena P, Rani R
Department of Obstetrics and Gynaecology, JIPMER , Puducherry , India.
J Obstet Gynaecol. 2014 May;34(4):322-5. doi: 10.3109/01443615.2013.874407. Epub 2014 Jan 31.
The aim of our study was to compare the efficacy and safety of nifedipine and progesterone for maintenance tocolysis after arrested preterm labour, in prolonging pregnancy and preventing recurrence of preterm labour. This study was a randomised comparative study conducted on 110 pregnant women with arrested preterm labour, randomised to receive either nifedipine 20 mg Q 8-hourly or progesterone 400 mg daily for maintenance tocolysis. Other than demographic parameters, obstetric parameters like previous history of abortions or preterm deliveries, gestational age, cervical dilatation and effacement, ultrasound measured cervical length at admission, were noted. Outcome measures studied were mean prolongation of pregnancy, mode of delivery, neonatal outcome and side-effects of both the drugs. We found that there was no significant difference in the demographic profile, parity, number of abortions, previous preterm deliveries, gestational age, cervical dilatation and effacement at admission between the two groups. A total of 10% of the patients in the nifedipine group and 61% of the patients in the progesterone group delivered at term (p value 0.000). The mean prolongation of pregnancy in the nifedipine group was 16.63 days and 40.14 days in the progesterone group which was significant (p = 0.000). Neonates in the progesterone group had better birth weight, better Apgar scores at 1 and 5 min, lesser need for ventilation and significantly lesser composite morbidity. Nifedipine was associated significantly with side-effects. We conclude that when compared with nifedipine, progesterone significantly prolongs pregnancy in women with arrested preterm labour with better neonatal outcomes and fewer side-effects.
我们研究的目的是比较硝苯地平和孕酮在治疗早产停滞后维持宫缩抑制、延长孕周及预防早产复发方面的疗效和安全性。本研究是一项随机对照研究,对110例早产停滞的孕妇进行,随机分为两组,一组每8小时口服20 mg硝苯地平进行维持宫缩抑制,另一组每日口服400 mg孕酮进行维持宫缩抑制。记录了除人口统计学参数外的其他产科参数,如既往流产或早产史、孕周、宫颈扩张和消退情况、入院时超声测量的宫颈长度。研究的结局指标包括孕周的平均延长时间、分娩方式、新生儿结局以及两种药物的副作用。我们发现两组在人口统计学特征、产次、流产次数、既往早产史、孕周、入院时宫颈扩张和消退情况方面无显著差异。硝苯地平组10%的患者和孕酮组61%的患者足月分娩(p值0.000)。硝苯地平组孕周的平均延长时间为16.63天,孕酮组为40.14天,差异有统计学意义(p = )。孕酮组新生儿出生体重更好在1分钟和5分钟时阿氏评分更高,通气需求更少,综合发病率显著更低。硝苯地平与副作用显著相关。我们得出结论,与硝苯地平相比,孕酮能显著延长早产停滞妇女的孕周,新生儿结局更好,副作用更少。